Preclinical Evaluation of 203Pb- and 212Pb-Labeled mcp-PSMA Ligands for Radionuclide Theranostics of Prostate Cancer Article Swipe
Magdalena Blei
,
Katarína Hajduová
,
Zbyněk Nový
,
Miloš Petřík
,
Santiago Brühlmann
,
Marc Pretze
,
Sven Stadlbauer
,
Klaus Kopka
,
Constantin Mamat
·
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.1016/j.nucmedbio.2025.109097
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.1016/j.nucmedbio.2025.109097
Related Topics
Concepts
No concepts available.
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1016/j.nucmedbio.2025.109097
- OA Status
- hybrid
- OpenAlex ID
- https://openalex.org/W4416072398
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4416072398Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1016/j.nucmedbio.2025.109097Digital Object Identifier
- Title
-
Preclinical Evaluation of 203Pb- and 212Pb-Labeled mcp-PSMA Ligands for Radionuclide Theranostics of Prostate CancerWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2025Year of publication
- Publication date
-
2025-11-01Full publication date if available
- Authors
-
Magdalena Blei, Katarína Hajduová, Zbyněk Nový, Miloš Petřík, Santiago Brühlmann, Marc Pretze, Sven Stadlbauer, Klaus Kopka, Constantin MamatList of authors in order
- Landing page
-
https://doi.org/10.1016/j.nucmedbio.2025.109097Publisher landing page
- Open access
-
YesWhether a free full text is available
- OA status
-
hybridOpen access status per OpenAlex
- OA URL
-
https://doi.org/10.1016/j.nucmedbio.2025.109097Direct OA link when available
- Cited by
-
0Total citation count in OpenAlex
Full payload
| id | https://openalex.org/W4416072398 |
|---|---|
| doi | https://doi.org/10.1016/j.nucmedbio.2025.109097 |
| ids.doi | https://doi.org/10.1016/j.nucmedbio.2025.109097 |
| ids.openalex | https://openalex.org/W4416072398 |
| fwci | 0.0 |
| type | article |
| title | Preclinical Evaluation of 203Pb- and 212Pb-Labeled mcp-PSMA Ligands for Radionuclide Theranostics of Prostate Cancer |
| biblio.issue | |
| biblio.volume | 150-151 |
| biblio.last_page | 109097 |
| biblio.first_page | 109097 |
| is_xpac | False |
| apc_list.value | 3270 |
| apc_list.currency | USD |
| apc_list.value_usd | 3270 |
| apc_paid.value | 3270 |
| apc_paid.currency | USD |
| apc_paid.value_usd | 3270 |
| language | en |
| locations[0].id | doi:10.1016/j.nucmedbio.2025.109097 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S24354371 |
| locations[0].source.issn | 0969-8051, 1872-9614 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | False |
| locations[0].source.issn_l | 0969-8051 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | Nuclear Medicine and Biology |
| locations[0].source.host_organization | https://openalex.org/P4310320990 |
| locations[0].source.host_organization_name | Elsevier BV |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310320990 |
| locations[0].license | cc-by |
| locations[0].pdf_url | |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Nuclear Medicine and Biology |
| locations[0].landing_page_url | https://doi.org/10.1016/j.nucmedbio.2025.109097 |
| indexed_in | crossref |
| authorships[0].author.id | https://openalex.org/A5021603856 |
| authorships[0].author.orcid | https://orcid.org/0009-0009-1358-3560 |
| authorships[0].author.display_name | Magdalena Blei |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Magdalena Blei |
| authorships[0].is_corresponding | False |
| authorships[1].author.id | https://openalex.org/A5116594034 |
| authorships[1].author.orcid | https://orcid.org/0009-0000-3078-0907 |
| authorships[1].author.display_name | Katarína Hajduová |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Katarína Hajduová |
| authorships[1].is_corresponding | False |
| authorships[2].author.id | https://openalex.org/A5085313408 |
| authorships[2].author.orcid | https://orcid.org/0000-0002-7716-2142 |
| authorships[2].author.display_name | Zbyněk Nový |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Zbynek Novy |
| authorships[2].is_corresponding | False |
| authorships[3].author.id | https://openalex.org/A5008297647 |
| authorships[3].author.orcid | |
| authorships[3].author.display_name | Miloš Petřík |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Milos Petrik |
| authorships[3].is_corresponding | False |
| authorships[4].author.id | https://openalex.org/A5072882517 |
| authorships[4].author.orcid | |
| authorships[4].author.display_name | Santiago Brühlmann |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Santiago Brühlmann |
| authorships[4].is_corresponding | False |
| authorships[5].author.id | https://openalex.org/A5052806645 |
| authorships[5].author.orcid | https://orcid.org/0000-0002-6432-5694 |
| authorships[5].author.display_name | Marc Pretze |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Marc Pretze |
| authorships[5].is_corresponding | False |
| authorships[6].author.id | https://openalex.org/A5001927919 |
| authorships[6].author.orcid | https://orcid.org/0000-0003-2276-5330 |
| authorships[6].author.display_name | Sven Stadlbauer |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Sven Stadlbauer |
| authorships[6].is_corresponding | False |
| authorships[7].author.id | https://openalex.org/A5042184078 |
| authorships[7].author.orcid | https://orcid.org/0000-0003-4846-1271 |
| authorships[7].author.display_name | Klaus Kopka |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Klaus Kopka |
| authorships[7].is_corresponding | False |
| authorships[8].author.id | https://openalex.org/A5003326735 |
| authorships[8].author.orcid | https://orcid.org/0000-0003-1906-3186 |
| authorships[8].author.display_name | Constantin Mamat |
| authorships[8].author_position | last |
| authorships[8].raw_author_name | Constantin Mamat |
| authorships[8].is_corresponding | False |
| has_content.pdf | False |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://doi.org/10.1016/j.nucmedbio.2025.109097 |
| open_access.oa_status | hybrid |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-11-10T00:00:00 |
| display_name | Preclinical Evaluation of 203Pb- and 212Pb-Labeled mcp-PSMA Ligands for Radionuclide Theranostics of Prostate Cancer |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-28T10:02:02.716006 |
| primary_topic | |
| cited_by_count | 0 |
| locations_count | 1 |
| best_oa_location.id | doi:10.1016/j.nucmedbio.2025.109097 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S24354371 |
| best_oa_location.source.issn | 0969-8051, 1872-9614 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | False |
| best_oa_location.source.issn_l | 0969-8051 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | Nuclear Medicine and Biology |
| best_oa_location.source.host_organization | https://openalex.org/P4310320990 |
| best_oa_location.source.host_organization_name | Elsevier BV |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310320990 |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Nuclear Medicine and Biology |
| best_oa_location.landing_page_url | https://doi.org/10.1016/j.nucmedbio.2025.109097 |
| primary_location.id | doi:10.1016/j.nucmedbio.2025.109097 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S24354371 |
| primary_location.source.issn | 0969-8051, 1872-9614 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | False |
| primary_location.source.issn_l | 0969-8051 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | Nuclear Medicine and Biology |
| primary_location.source.host_organization | https://openalex.org/P4310320990 |
| primary_location.source.host_organization_name | Elsevier BV |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310320990 |
| primary_location.license | cc-by |
| primary_location.pdf_url | |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Nuclear Medicine and Biology |
| primary_location.landing_page_url | https://doi.org/10.1016/j.nucmedbio.2025.109097 |
| publication_date | 2025-11-01 |
| publication_year | 2025 |
| referenced_works_count | 0 |
| abstract_inverted_index | |
| cited_by_percentile_year | |
| countries_distinct_count | 0 |
| institutions_distinct_count | 9 |
| citation_normalized_percentile |